Development and validation of sensitive BCR::ABL1 fusion gene quantitation using next-generation seq...
Development and validation of sensitive BCR::ABL1 fusion gene quantitation using next-generation sequencing
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
BCR::ABL1 fusion has significant prognostic value and is screened for chronic myeloid leukemia (CML) disease monitoring as a part of routine molecular testing. To overcome the limitations of the current standard real-time quantitative polymerase chain reaction (RQ-PCR), we designed and validated a next-generation sequencing (NGS)-based assay to qua...
Alternative Titles
Full title
Development and validation of sensitive BCR::ABL1 fusion gene quantitation using next-generation sequencing
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5ce372cac67342f0bf2524e50b7e0109
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5ce372cac67342f0bf2524e50b7e0109
Other Identifiers
ISSN
1475-2867
E-ISSN
1475-2867
DOI
10.1186/s12935-023-02938-2
